Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Reviews Essential Drug Pricing Model After GMP Violations From Multi-bid Winner

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - While China implements a centralized tender system for essential drugs nationwide, the government also faces strong pushback from industry, which is questioning whether the current tender model is purely price competitive at the expense of quality. Following a product quality issue from a traditional Chinese medicine company that won essential drug tenders in several provinces, China's regulatory authority may consider modifying its approach

You may also be interested in...



Anhui Model Suggests More Pricing Pressure From Chinese Drug Tenders

HONG KONG - Meetings with government officials involved with the tender process in China's Anhui province suggest that the impact of price cuts for essential drugs has been greater than expected, Morgan Stanley analysts say in a June 6 research report

Anhui Model Suggests More Pricing Pressure From Chinese Drug Tenders

HONG KONG - Meetings with government officials involved with the tender process in China's Anhui province suggest that the impact of price cuts for essential drugs has been greater than expected, Morgan Stanley analysts say in a June 6 research report

In Brief

CDER reorganizes for global compliance

Latest News
UsernamePublicRestriction

Register

SC078358

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel